IDEXX Laboratories Inc

NASDAQ IDXX

Download Data

IDEXX Laboratories Inc Operating Cash Flow to Debt Ratio for the year ending December 31, 2023: 0.96

IDEXX Laboratories Inc Operating Cash Flow to Debt Ratio is 0.96 for the year ending December 31, 2023, a 137.49% change year over year. The operating cash flow to debt ratio measures the ability of a company's operating cash flow to cover its total debt obligations. It is calculated by dividing the operating cash flow by the total debt. This ratio provides insights into the company's ability to generate cash flow from its operations to service its debt. A higher ratio indicates a stronger capacity to generate operating cash flow relative to the level of debt, suggesting potential financial strength and debt servicing capability.
  • IDEXX Laboratories Inc Operating Cash Flow to Debt Ratio for the year ending December 31, 2022 was 0.40, a -50.77% change year over year.
  • IDEXX Laboratories Inc Operating Cash Flow to Debt Ratio for the year ending December 31, 2021 was 0.82, a 14.66% change year over year.
  • IDEXX Laboratories Inc Operating Cash Flow to Debt Ratio for the year ending December 31, 2020 was 0.71, a 53.45% change year over year.
  • IDEXX Laboratories Inc Operating Cash Flow to Debt Ratio for the year ending December 31, 2019 was 0.46, a 16.23% change year over year.
NASDAQ: IDXX

IDEXX Laboratories Inc

CEO Mr. Jonathan J. Mazelsky
IPO Date June 21, 1991
Location United States
Headquarters One IDEXX Drive, Westbrook, ME, United States, 04092
Employees 11,000
Sector Healthcare
Industry Diagnostics & research
Description

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Similar companies

WAT

Waters Corporation

NA

NA

CRL

Charles River Laboratories

NA

NA

RVTY

Revvity Inc.

NA

NA

A

Agilent Technologies Inc

NA

NA

DHR

Danaher Corporation

NA

NA

TWST

Twist Bioscience Corp

NA

NA

ICLR

ICON PLC

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email